Proft Fabian, Lüders Susanne, Hunter Theresa, Luna Gustavo, Rios Rodriguez Valeria, Protopopov Mikhail, Meier Katharina, Kokolakis Georgios, Ghoreschi Kamran, Poddubnyy Denis
Department of Gastroenterology, Infectiology and Rheumatology, Charite Universitatsmedizin Berlin Campus Benjamin Franklin, Berlin, Germany.
Department of Gastroenterology, Infectious Diseases and Rheumatology, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Berlin, Germany.
Ann Rheum Dis. 2022 Oct 12;81(11):1534-1540. doi: 10.1136/ard-2022-222562.
To evaluate a dermatologist-centred screening tool followed by a structured rheumatological examination including MRI of sacroiliac joints and spine for the recognition of psoriatic arthritis with axial involvement (axPsA).
This was a prospective multicentre study. Adult patients with a confirmed diagnosis of psoriasis who had chronic back pain (≥3 months), onset <45 years and had not been treated with any biologic or targeted synthetic disease-modifying antirheumatic drug in the 12 weeks before screening were referred to a specialised rheumatology clinic. A rheumatological investigation including clinical, laboratory and genetic assessments as well as imaging with conventional radiography and MRI of sacroiliac joints and spine was performed. The primary outcome of the study was the proportion of patients diagnosed with axPsA among all referred patients with PsO.
Rheumatologists examined 100 patients of those who qualified for referral. 14 patients (including 3 with both axial and peripheral involvement) were diagnosed with axPsA and 5 were diagnosed with peripheral PsA solely. All patients diagnosed with axPsA had active inflammatory and/or structural (post)inflammatory changes in the sacroiliac joints and/or spine on imaging. In five patients, MRI changes indicative of axial involvement were found only in the spine. All but one patient with PsA (13/14 with axPsA and 5/5 with pPsA) fulfilled the Classification Criteria for Psoriatic Arthritis criteria for PsA. The Assessment of SpondyloArthritis International Society criteria for axSpA were fulfilled in 9 (64.3%) patients diagnosed with axPsA.
Applying a dermatologist-centred screening tool may be useful for the early detection of axPsA in at-risk patients with psoriasis .
评估一种以皮肤科医生为主导的筛查工具,随后进行包括骶髂关节和脊柱磁共振成像(MRI)的结构化风湿病检查,以识别伴有轴向受累的银屑病关节炎(axPsA)。
这是一项前瞻性多中心研究。确诊为银屑病且有慢性背痛(≥3个月)、发病年龄<45岁且在筛查前12周内未接受任何生物制剂或靶向合成改善病情抗风湿药物治疗的成年患者被转诊至专门的风湿病诊所。进行了包括临床、实验室和基因评估以及骶髂关节和脊柱的传统X线摄影和MRI成像的风湿病调查。该研究的主要结局是在所有转诊的银屑病患者中被诊断为axPsA的患者比例。
风湿病医生检查了100名符合转诊条件的患者。14名患者(包括3名既有轴向又有外周受累的患者)被诊断为axPsA,5名患者仅被诊断为外周型银屑病关节炎(pPsA)。所有被诊断为axPsA的患者在影像学上骶髂关节和/或脊柱均有活动性炎症和/或结构性(后)炎症改变。在5名患者中,仅在脊柱中发现了提示轴向受累的MRI改变。除1名银屑病关节炎患者外(14名axPsA患者中的13名和5名pPsA患者中的5名),所有患者均符合银屑病关节炎分类标准。9名(64.3%)被诊断为axPsA的患者符合脊柱关节炎国际协会(ASAS)axSpA标准。
应用以皮肤科医生为主导的筛查工具可能有助于早期发现银屑病高危患者中的axPsA。